Previous Nav
Net Change on 12-09-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Divi's Laboratories Ltd.
Max Healthcare Institute Ltd.
Dr. Reddy's Laboratories Ltd.
Aster DM Healthcare Ltd.
Mankind Pharma Ltd.
Torrent Pharmaceuticals Ltd.
Krishna Inst of Medical Sciences Ltd.
Abbott India Ltd.
Global Health Ltd.
Ajanta Pharma Ltd.
PB Fintech Ltd.
Dr. Lal Path Labs Ltd.
Cipla Ltd.
Jupiter Life Line Hospitals Ltd.
ICICI Lombard General Insurance Co. Ltd.
Navin Fluorine International Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Neuland Laboratories Ltd.
Rainbow Children's Medicare Ltd.
IPCA Laboratories Ltd.
Sai Life Sciences Ltd
Sagility India Ltd.
Clearing Corporation of India Ltd.
Anthem Biosciences Ltd.
Zydus Lifesciences Ltd.
Syngene International Ltd.
Orchid Pharma Ltd.
Dr Agarwal's Eye Hospital Ltd.
Dr Agarwal's Health Care Ltd.
Net Receivables / (Payables)
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Fintech
Business Support
Insurance
Chemicals
Miscellaneous
Cash
Equity
PGIM India Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to PGIM India Mutual Fund. It was launched on 06-Dec-2024 and currently has an AUM of ₹107.37 crore. PGIM India Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.
The NAV of PGIM India Healthcare Fund ended up ₹0.02(0.2%)yesterday to ₹9.92.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The PGIM India Healthcare Fund is managed by Puneet Pal and Anandha Padmanabhan Anjeneyan.
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051